Mustargen Powder For Solution For Injection 10Mg Drug Medication Dosage Information
show timeout overlay link

Your Session Is About to Expire

This online session is about to expire due to inactivity. Click Continue to return to page.

  • myWeekly Ad

Mustargen: Powder for solution for injection (10mg)

Also see:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics

Visit Drug Summary Page
Drug Image file default-drug-image.png


What is this Medicine?

MECHLORETHAMINE (me klor ETH a meen) is a chemotherapy drug. This medicine is used to treat many types of cancer like Hodgkin's disease, non-Hodgkin's lymphoma, mycosis fungoides, and some blood and lung cancers.

In-Depth Information
Select a Medication

Mustargen 10mg Powder for Injection

NDC: 552920911
  • Prescription Required
  • Not a Controlled Drug
    (CSA Schedule)
  • FDA Approved




FDA approved for the following conditions:
Lung Cancer, Mycosis Fungoides, Pericardial Effusion, Chronic Lymphocytic Leukemia (CLL), Hodgkin's Disease, Cutaneous T-cell Lymphoma (CTCL), Polycythemia Vera, Chronic Myelogenous Leukemia (CML), Pleural Effusion, Peritoneal Effusion

Storage Information
Store at room temperature (between 59 to 86 degrees F)
Protect from light
Discard product if it contains particulate matter, is cloudy, or discolored
Avoid excessive humidity
Mustargen 10mg Powder for Injection

Reported Side Effects for Mustargen 10mg Powder for Injection

Anemia Incidence:
<13.0%*
Severity: MODERATE
Onset: DELAYED
Low White Blood Cells Incidence:
<13.0%*
Severity: MODERATE
Onset: DELAYED
Low Platelet Count Incidence:
<13.0%*
Severity: MODERATE
Onset: DELAYED
Secondary Malignancy Incidence:
2.0%*
Severity: MODERATE
Onset: DELAYED
Infection Incidence:
2.0%*
Severity: SEVERE
Onset: DELAYED
Skin Ulcer Incidence:
3.0%*
Severity: SEVERE
Onset: DELAYED
*This is an approximate aggregated range of reported side effects from clinical studies performed on this drug. Your experience with this drug may be different.
Pregnancy & Lactation Information
FIRST Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

SECOND Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

THIRD Trimester

Class D - Adequate well-controlled or observational studies in pregnant women have demonstrated a risk to the fetus. However, the benefits of therapy may outweigh the potential risk. For example, the drug may be acceptable if needed in a life-threatening situation or serious disease for which safer drugs cannot be used or are ineffective.

Lactation

Avoid - This drug is known to cause harm to infants when taken by nursing mothers.


Learning More About
Visit the Drug Summary page where you can:
  • Get answers to Frequently Asked Questions (FAQs)
  • Find other class related drugs
  • Find additional patient usage statistics
Learn More
Patient Experiences with Mustargen

Be the first to share your experience!

We want to help our customers stay educated about the medications they are taking. Submit your own observations and experiences to benefit others.

Average Scores
Easy to Take 
0 / 5
0 / 5
Works as Intended 
0 / 5
0 / 5
Tolerable 
0 / 5
0 / 5